W

WSI Co Ltd
KOSDAQ:299170

Watchlist Manager
WSI Co Ltd
KOSDAQ:299170
Watchlist
Price: 3 210 KRW Market Closed
Market Cap: ₩133.2B

WSI Co Ltd
Total Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

WSI Co Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
W
WSI Co Ltd
KOSDAQ:299170
Total Equity
₩41.4B
CAGR 3-Years
8%
CAGR 5-Years
38%
CAGR 10-Years
N/A
C
Chorokbaem Healthcare Co Ltd
KRX:118000
Total Equity
₩115.7B
CAGR 3-Years
-1%
CAGR 5-Years
26%
CAGR 10-Years
30%
W
Wonik Co Ltd
KOSDAQ:032940
Total Equity
₩282.9B
CAGR 3-Years
6%
CAGR 5-Years
25%
CAGR 10-Years
20%
H
HLB Life Science Co Ltd
KOSDAQ:067630
Total Equity
₩276.9B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
52%
B
BlueMTec Co Ltd
KOSDAQ:439580
Total Equity
₩47.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

WSI Co Ltd
Glance View

Market Cap
133.2B KRW
Industry
Health Care

WSI Co., Ltd. manufactures medical devices and pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-09-21. The firm mainly distributes the topical hemostatic agent Flosils. In addition, the Company supplies endoscopes related to spinal surgery, anti-adhesion agents, and bone hemostatic agents.

Intrinsic Value
1 696.71 KRW
Overvaluation 47%
Intrinsic Value
Price ₩3 210
W

See Also

What is WSI Co Ltd's Total Equity?
Total Equity
41.4B KRW

Based on the financial report for Dec 31, 2024, WSI Co Ltd's Total Equity amounts to 41.4B KRW.

What is WSI Co Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
38%

Over the last year, the Total Equity growth was 3%. The average annual Total Equity growth rates for WSI Co Ltd have been 8% over the past three years , 38% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett